Beijing, China

Danqing Song

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignees: Guangzhou Hc Pharmaceutical Co. Ltd, Institute of Medicinal Biotechnology, Chinese Academy of Medical, Tsinghua University. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Danqing Song

Introduction

Danqing Song is a notable inventor based in Beijing, China. He has made significant contributions to the field of medicinal biotechnology, particularly through his innovative research and development of pharmaceutical compounds. His work focuses on creating effective treatments for various bacterial infections.

Latest Patents

Danqing Song holds a patent for a β-lactam compound, which includes a unique preparation method and its applications. This compound demonstrates excellent antibacterial properties, particularly against gram-negative bacteria. It is characterized by low drug resistance and shows promising potential for treating a variety of medical conditions.

Career Highlights

Throughout his career, Danqing Song has worked with prestigious organizations, including the Institute of Medicinal Biotechnology at the Chinese Academy of Medical Sciences and Guangzhou Hc Pharmaceutical Co. Ltd. His experience in these institutions has allowed him to advance his research and contribute to the development of new therapeutic solutions.

Collaborations

Danqing has collaborated with several esteemed colleagues, including Zhiwen Li and Yanxiang Wang. Their joint efforts have further enhanced the impact of his research in the field of medicinal biotechnology.

Conclusion

Danqing Song's innovative work in developing antibacterial compounds highlights his significant contributions to medical science. His research not only addresses critical health challenges but also paves the way for future advancements in pharmaceutical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…